[HTML][HTML] Construction and applications of SARS-CoV-2 pseudoviruses: a mini review

M Chen, XE Zhang - International journal of biological sciences, 2021 - ncbi.nlm.nih.gov
The ongoing coronavirus disease 2019 pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has posed a serious threat to global public health …

[HTML][HTML] Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges

E Amanatidou, A Gkiouliava, E Pella, M Serafidi… - Metabolism open, 2022 - Elsevier
Vaccination programs against SARS-CoV-2 constitute the mainstay of public health
interventions against the global COVID-19 pandemic. Currently available vaccines have …

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses

BL Sievers, S Chakraborty, Y Xue, T Gelbart… - Science translational …, 2022 - science.org
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that have
mutations associated with increased transmission and antibody escape have arisen over the …

Current status on the development of pseudoviruses for enveloped viruses

Q Li, Q Liu, W Huang, X Li… - Reviews in medical …, 2018 - Wiley Online Library
Emerging and reemerging infectious diseases have a strong negative impact on public
health. However, because many of these pathogens must be handled in biosafety level, 3 or …

Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature

D Cantoni, C Wilkie, EM Bentley… - Frontiers in …, 2023 - frontiersin.org
Background The virus neutralization assay is a principal method to assess the efficacy of
antibodies in blocking viral entry. Due to biosafety handling requirements of viruses …

Uses and challenges of antiviral polyclonal and monoclonal antibody therapies

EB Struble, JMO Rawson, T Stantchev, D Scott… - Pharmaceutics, 2023 - mdpi.com
Viral diseases represent a major public health concerns and ever-present risks for
developing into future pandemics. Antiviral antibody therapeutics, either alone or in …

Production, titration, neutralisation, storage and lyophilisation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lentiviral pseudotypes

C Di Genova, A Sampson, S Scott, D Cantoni… - Bio …, 2021 - bio-protocol.org
This protocol details a rapid and reliable method for the production and titration of high-titre
viral pseudotype particles with the SARS-CoV-2 spike protein (and D614G or other variants …

Coronavirus pseudotypes for all circulating human coronaviruses for quantification of cross-neutralizing antibody responses

AT Sampson, J Heeney, D Cantoni, M Ferrari, MS Sans… - Viruses, 2021 - mdpi.com
The novel coronavirus SARS-CoV-2 is the seventh identified human coronavirus.
Understanding the extent of pre-existing immunity induced by seropositivity to endemic …

Influenza virus genotype to phenotype predictions through machine learning: a systematic review: computational prediction of influenza phenotype

LK Borkenhagen, MW Allen… - Emerging microbes & …, 2021 - Taylor & Francis
Background: There is great interest in understanding the viral genomic predictors of
phenotypic traits that allow influenza A viruses to adapt to or become more virulent in …

More than just gene therapy vectors: Lentiviral vector pseudotypes for serological investigation

K Toon, EM Bentley, G Mattiuzzo - Viruses, 2021 - mdpi.com
Serological assays detecting neutralising antibodies are important for determining the
immune responses following infection or vaccination and are also often considered a …